Variations in the Type of Adjuvant Chemotherapy Among Stage III Colon Cancer Patients in England

被引：0
|
作者：
Syreen Hassan
Anne Miles
Bernard Rachet
Melanie Morris
机构：
[1] Department of Health Services Research and Policy,Department of Psychological Sciences
[2] London School of Hygiene and Tropical Medicine,Department of Non
[3] Birkbeck,communicable Disease Epidemiology
[4] University of London,undefined
[5] London School of Hygiene and Tropical Medicine,undefined
来源：
Journal of Gastrointestinal Cancer | 2023年 / 54卷
关键词：
Adjuvant chemotherapy; Colon cancer; Fluoropyrimidine; Oxaliplatin; Inequalities;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1193 / 1201
页数：8
相关论文
共 50 条
  • [41] Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?
    Berglund, A.
    Cedermark, B.
    Glimelius, B.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 400 - 402
  • [42] Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer
    Turner, Megan C.
    Farrow, Norma E.
    Rhodin, Kristen E.
    Sun, Zhifei
    Adam, Mohamed A.
    Mantyh, Christopher R.
    Migaly, John
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (04) : 670 - 678
  • [43] The role of adjuvant chemotherapy in stage II and III mucinous colon cancer
    Fields, Adam C.
    Lu, Pamela
    Goldberg, Joel
    Irani, Jennifer
    Bleday, Ronald
    Melnitchouk, Nelya
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1190 - 1200
  • [44] Preference values associated with stage III colon cancer and adjuvant chemotherapy
    Best, Jennie H.
    Garrison, Louis P.
    Hollingworth, William
    Ramsey, Scott D.
    Veenstra, David L.
    QUALITY OF LIFE RESEARCH, 2010, 19 (03) : 391 - 400
  • [45] Utilisation of adjuvant chemotherapy for people with stage III colon cancer in NSW
    You, Hui
    Morrell, Stephen
    Lin, Enmoore
    Tervonen, Hanna
    Zhao, George
    Currow, David
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 57 - 57
  • [46] Adjuvant Chemotherapy for Stage III Colon Cancer: Does Timing Matter?
    Czaykowski, Piotr M.
    Gill, Sharlene
    Kennecke, Hagen F.
    Gordon, Vallerie L.
    Turner, Donna
    DISEASES OF THE COLON & RECTUM, 2011, 54 (09) : 1082 - 1089
  • [47] A statewide evaluation of adjuvant chemotherapy for stage III colon cancer.
    Petrelli, N. J.
    Grubbs, S. S.
    Spellman, J. E.
    English, C. L.
    Shevock, A.
    Nunley, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] The Course of Neuropathic Symptoms in Relation to Adjuvant Chemotherapy Among Elderly Patients With Stage III Colon Cancer: A Longitudinal Study
    van Erning, Felice N.
    Janssen-Heijnen, Maryska L. G.
    Wegdam, Johannes A.
    Slooter, Gerrit D.
    Wijsman, Jan H.
    Vreugenhil, Art
    Beijers, Tonneke A. J. M.
    van de Poll-Franse, Lonneke V.
    Lemmens, Valery E. P. P.
    CLINICAL COLORECTAL CANCER, 2017, 16 (03) : 195 - 203
  • [49] Outcomes Among Black Patients With Stage II and III Colon Cancer Receiving Chemotherapy: An Analysis of ACCENT Adjuvant Trials
    Yothers, Greg
    Sargent, Daniel J.
    Wolmark, Norman
    Goldberg, Richard M.
    O'Connell, Michael J.
    Benedetti, Jacqueline K.
    Saltz, Leonard B.
    Dignam, James J.
    Blackstock, A. William
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (20) : 1498 - 1506
  • [50] Trends in Adjuvant Chemotherapy Use Among Stage III Colon Cancer in Non-Elderly and Low Comorbidity Patients
    El Hajj, Joanna
    Soleja, Mohsin
    Goksu, Suleyman Y.
    Ah, Chul
    Sanford, Nina N.
    Karagkounis, Georgios
    Pogacnik, Javier S.
    Ali, Fadwa
    Chilakamarry, Sitaram
    Kainthla, Radhika
    Hsiehchen, David
    Jones, Amy L.
    Al Mutar, Salwan
    Sanjeevaiah, Aravind
    Beg, Muhammad S.
    Huang, Emina H.
    Kazmi, Syed M.
    CLINICAL COLORECTAL CANCER, 2022, 21 (04) : 315 - 324
12345